ResearcherNational Health Research InstitutesNo recent work listed
Yen‐Feng Chiu
Matched on ORCID iD 0000-0002-3352-4500; OpenAlex author ID A5082736904, A5110097488. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 4
- Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which P… Co-author DOI 10.1016/j.ijrobp.2023.02.061↗
- A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative On… First author DOI 10.1038/s41416-021-01649-7↗
- The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis. First author DOI 10.4143/crt.2017.105↗
- Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced… Co-author DOI 10.1016/j.ijrobp.2010.10.034↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Li‐Tzong Chen · 4 shared papers, 2011–2023 · strength 0.45
- Paper Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected P… DOI 10.1016/j.ijrobp.2023.02.061↗
- Paper A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced panc… DOI 10.1038/s41416-021-01649-7↗
- Paper The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Sy… DOI 10.4143/crt.2017.105↗
- Hui-Ju Ch’ang · 4 shared papers, 2011–2023 · strength 0.45
- Paper Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected P… DOI 10.1016/j.ijrobp.2023.02.061↗
- Paper A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced panc… DOI 10.1038/s41416-021-01649-7↗
- Paper The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Sy… DOI 10.4143/crt.2017.105↗
- Yan‐Shen Shan · 3 shared papers, 2011–2023 · strength 0.34
- Paper Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected P… DOI 10.1016/j.ijrobp.2023.02.061↗
- Paper A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced panc… DOI 10.1038/s41416-021-01649-7↗
- Paper Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiot… DOI 10.1016/j.ijrobp.2010.10.034↗
- Chung‐Pin Li · 2 shared papers, 2022–2023 · strength 0.32
- Paper Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected P… DOI 10.1016/j.ijrobp.2023.02.061↗
- Paper A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced panc… DOI 10.1038/s41416-021-01649-7↗
- Jen‐Shi Chen · 2 shared papers, 2011–2023 · strength 0.20
- Paper Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected P… DOI 10.1016/j.ijrobp.2023.02.061↗
- Paper Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiot… DOI 10.1016/j.ijrobp.2010.10.034↗
- Tsann‐Long Hwang · 2 shared papers, 2011–2023 · strength 0.20
- Paper Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected P… DOI 10.1016/j.ijrobp.2023.02.061↗
- Paper Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiot… DOI 10.1016/j.ijrobp.2010.10.034↗
- Nai‐Jung Chiang · 1 shared paper, 2022 · strength 0.15
- Yung‐Yeh Su · 1 shared paper, 2022 · strength 0.15
- Shih‐Hung Yang · 1 shared paper, 2022 · strength 0.15
- Jeffrey Shu-Ming Chang · 1 shared paper, 2018 · strength 0.11
- Yu‐Wen Tien · 1 shared paper, 2011 · strength 0.02
- Ann‐Lii Cheng · 1 shared paper, 2011 · strength 0.02
- Ming‐Chu Chang · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.